Cancer Immunotherapy Proved to be Fertile Ground for Personalized Medicine
Written by Dr. Attila Berces, Chairman at Omixon. Share the original article on LinkedIn here… “We try to remember that medicine is for the patient. We try never to forget that medicine is for the people. It is not for the profits. The profits follow, and if we have...